1-4 of 4
Tae Kon Kim, M.D.
Close
Sort by
Journal Articles

MEK Inhibitors Selectively Suppress Human T Cell Alloreactivity in a Memory Stage-Dependent Manner,

Takero Shindo, M.D., Ph.D., Tae Kon Kim, M.D., Ph.D., Cara L. Benjamin, Ph.D., Robert B. Levy, Ph.D., Eric D. Wieder, Ph.D., Krishna V. Komanduri, M.D.
Journal: Blood
Blood (2011) 118 (21): 4014.
https://doi.org/10.1182/blood.V118.21.4014.4014
Published: 2011
Journal Articles

Targeting of alpha4beta1 Integrin and CD4/CD8 on Human T Cells, in Addition to CD3 and CD28, Induces Maximal Activation, as Assessed by Single-Cell Analysis of MAP Kinase Pathway Activation and Cytokine Production.

Tae Kon Kim, M.D., Matthew J. Billard, Ph.D., Eric D. Wieder, Ph.D., Bradley W. McIntyre, Ph.D., Krishna V. Komanduri, M.D.
Journal: Blood
Blood (2008) 112 (11): 1538.
https://doi.org/10.1182/blood.V112.11.1538.1538
Published: 2008
Journal Articles

Cytokine Production Signatures Are Intrinsically Associated with Human T Cell Maturation Stages.

Krishna V. Komanduri, MD, Tae Kon Kim, M.D., Eric D. Wieder, Ph.D., Lisa S. St. John, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1337.
https://doi.org/10.1182/blood.V110.11.1337.1337
Published: 2007
Journal Articles

Acute Myeloid Leukemia Cells Contain Constitutively Activated STAT3 and Require STAT3 for Survival.

Tae Kon Kim, M.D., Martin Carroll, M.D., Alan M. Gewirtz, M.D.
Journal: Blood
Blood (2004) 104 (11): 3368.
https://doi.org/10.1182/blood.V104.11.3368.3368
Published: 2004